Clinical Trial Update: CQSP in Malawi: Chloroquine and Sulfadoxine-pyrimethamine Efficacy for the Treatment of Malaria in Malawi [Phase 4]

View source ↗

Summary

Phase 4 trial in Malawi evaluated the efficacy of chloroquine and sulfadoxine-pyrimethamine for treating malaria caused by Plasmodium falciparum; the study has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria
• Plasmodium Falciparum Malaria

Drugs mentioned

• Chloroquine (chloroquine)
• Sulfadoxine-pyrimethamine (sulfadoxine-pyrimethamine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Malaria, Plasmodium Falciparum Malaria | Phase 4 | Status: COMPLETED